Der Ziege Polyklonal anti-Influenza A Virus H3N2 Antikörper wird verwendet zum Nachweis von Influenza A Virus H3N2 in Proben von Influenza A Virus H3N2. Er wurde validiert für IF und EIA.
Suitable for use in ELISA and Fluorescence Microscopy. Also suitable for conjugation purposes. Titer: > 1/1,000 (Indirect Immunofluorescence), > 1/2,500 (Hemagglutination Inhibition). Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
4-5 mg/mL (OD280, E0.1% = 1.4)
Buffer
0.01 M PBS pH 7.2 containing 0.09 % sodium azide as a preservative without stabilizing proteins.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Avoid repeated freezing and thawing.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Target
Influenza A Virus H3N2
Andere Bezeichnung
Influenza A H3N2
Substanzklasse
Influenza Virus
Hintergrund
Influenza A and B are the two types of influenza viruses that cause epidemic human disease. Influenza type C infections cause a mild respiratory illness and are not thought to cause epidemics. Influenza A viruses are further categorized into subtypes on the basis of two surface antigens: hemagglutinin (H) and neuraminidase (N). Strains are also described by geographic origin, strain number and year of isolation.Synonyms: Seasonal Flu H3N2